1. Sublingual apomorphine (APL‐130277) for the acute conversion of OFF to ON in Parkinson's disease. Issue 9 (19th July 2016) Authors: Hauser, Robert A.; Olanow, C. Warren; Dzyngel, Bruce; Bilbault, Thierry; Shill, Holly; Isaacson, Stuart; Dubow, Jordan; Agro, Albert Other Names: Sánchez‐Ferro Álvaro guestEditor.; Maetzler Walter guestEditor. Journal: Movement disorders Issue: Volume 31:Issue 9(2016) Page Start: 1366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Buccal mucosal irritation studies of sublingual apomorphine film (APL-130277) in Syrian golden hamsters. (September 2016) Authors: Bilbault, Thierry; Taylor, Simon; Walker, Robin; Grundy, Starr L; Pappert, Eric J; Agro, Albert Journal: Therapeutic delivery Issue: Volume 7:Number 9(2016) Page Start: 611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of sublingual apomorphine (APL-130277) for the treatment of off episodes in patients with Parkinson's disease. (January 2016) Authors: Agro, Albert; Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Shill, Holly; Hauser, Robert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the off to on state. (January 2016) Authors: Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Agro, Albert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the off to full on state with sublingual apomorphine (APL-130277). (January 2016) Authors: Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Agro, Albert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease. (January 2016) Authors: Agro, Albert; Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Shill, Holly; Hauser, Robert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Safety of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease. (January 2016) Authors: Agro, Albert; Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Isaacson, Stuart Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Baseline disease severity not predictive of sublingual apomorphine (APL-130277) dose needed to convert a PD patient from the OFF to ON state. (January 2016) Authors: Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Agro, Albert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effects of sublingual apomorphine (APL-130277) by disease severity on the acute reversal of OFF episodes in Parkinson's disease patients. (January 2016) Authors: Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Agro, Albert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Minimum MDS-UPDRS part III change needed to convert a Parkinson's disease patient from the OFF to full ON state with sublingual apomorphine (APL-130277). (January 2016) Authors: Dubow, Jordan; Dzyngel, Bruce; Bilbault, Thierry; Giovinazzo, Anthony; Agro, Albert Journal: Parkinsonism & related disorders Issue: Volume 22(2016)Supplement 2 Page Start: e104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗